Jun 13, 2024

Expert Tip: Invest in Education and Oversight to Successfully Navigate the 340B Program

TIP: Dedicating resources and ensuring team members have access to education & information are essential to successfully navigating the 340B program.

The 340B program, with its complexities and frequent regulatory updates, demands careful attention to maximize savings and ensure compliance. To effectively manage the program, it is important that to dedicate resources capable of overseeing the various components of the program, emphasize thorough training, and facilitate access to essential resources.

Investing in Continuous Education: Keeping staff updated on compliance requirements and the ever-evolving legislative and pharmaceutical manufacturer changes is essential. Continuous education initiatives enable team members to accurately navigate the program’s complexities. Training in proper data management practices emphasizes the importance of data integrity in maintaining compliance and preventing costly consequences.

Prioritizing Oversight and Resources: Successful 340B programs often allocate dedicated resources for oversight, provide ongoing learning opportunities for the team to stay current with regulatory changes. Ensuring resources are dedicated to programmatic reviews can also help prevent errors and enhance program performance.

Encouraging a Culture of Learning: Promoting a culture of continuous learning can uplift staff morale and empower team members to tackle challenges with confidence. By ensuring adequate resources are available for programmatic reviews, organizations can achieve greater success with their 340B program.

Fostering Collaboration: Collaboration with internal and external stakeholders is essential. This includes working with pharmacies, manufacturers, and regulatory bodies to streamline operations and address any issues promptly. Effective communication and partnerships can lead to improved program outcomes and increased savings.

By adopting a proactive approach to education, oversight, and collaboration, organizations can navigate the complexities of the 340B program with confidence. This strategy not only ensures compliance and maximizes savings but also enhances the overall effectiveness of the organization. Embracing these practices will lead to sustained success and better outcomes for patients.

Recent Articles

Pillr Health and Sam’s Club Partner to Launch a New Era of 340B Contract Pharmacy Services

Pillr Health is proud to announce a new national relationship with Sam’s Club.

Beginning January 1, 2026, Sam’s Club will use Highbridge, the 340B data-processing technology developed by Pillr Health, as its platform for managing all 340B contract pharmacy relationships.

This collaboration marks Sam’s Club’s first participation in the 340B program, creating new opportunities for Covered Entities to expand their networks and capture untapped program value. By leveraging Highbridge, Sam’s Club will deliver standardized, scalable, and compliant 340B services across its pharmacy network: ensuring consistency, transparency, and growth potential for partners nationwide.

Expanding Access, Empowering Growth

Through this partnership, Sam’s Club and Pillr Health are delivering a scalable technology framework that streamlines 340B operations and strengthens collaboration across the program’s national network.

“This partnership represents a pivotal step forward for both organizations,” said Skip Devanny, CEO of Pillr Health. “By combining Sam’s Club’s national reach with Pillr’s advanced technology, we’re enabling a new era of collaboration and value creation across the 340B ecosystem.”

A Shared Commitment to the 340B Mission

At its core, this partnership is about more than technology. It is about advancing the mission of 340B by expanding access, improving affordability, and empowering providers to reinvest in patient care.

Through this collaboration, Sam’s Club and Pillr Health are building a strong foundation for sustained 340B growth, helping safety-net providers strengthen compliance, increase savings, and extend their impact in the communities that need it most.

Pillr Health and Sam’s Club Partner to Launch a New Era of 340B Contract Pharmacy Services

Pillr Health is proud to announce a new national relationship with Sam’s Club.

Beginning January 1, 2026, Sam’s Club will use Highbridge, the 340B data-processing technology developed by Pillr Health, as its platform for managing all 340B contract pharmacy relationships.

This collaboration marks Sam’s Club’s first participation in the 340B program, creating new opportunities for Covered Entities to expand their networks and capture untapped program value. By leveraging Highbridge, Sam’s Club will deliver standardized, scalable, and compliant 340B services across its pharmacy network: ensuring consistency, transparency, and growth potential for partners nationwide.

Expanding Access, Empowering Growth

Through this partnership, Sam’s Club and Pillr Health are delivering a scalable technology framework that streamlines 340B operations and strengthens collaboration across the program’s national network.

“This partnership represents a pivotal step forward for both organizations,” said Skip Devanny, CEO of Pillr Health. “By combining Sam’s Club’s national reach with Pillr’s advanced technology, we’re enabling a new era of collaboration and value creation across the 340B ecosystem.”

A Shared Commitment to the 340B Mission

At its core, this partnership is about more than technology. It is about advancing the mission of 340B by expanding access, improving affordability, and empowering providers to reinvest in patient care.

Through this collaboration, Sam’s Club and Pillr Health are building a strong foundation for sustained 340B growth, helping safety-net providers strengthen compliance, increase savings, and extend their impact in the communities that need it most.

Pillr Health and Sam’s Club Partner to Launch a New Era of 340B Contract Pharmacy Services

Pillr Health is proud to announce a new national relationship with Sam’s Club.

Beginning January 1, 2026, Sam’s Club will use Highbridge, the 340B data-processing technology developed by Pillr Health, as its platform for managing all 340B contract pharmacy relationships.

This collaboration marks Sam’s Club’s first participation in the 340B program, creating new opportunities for Covered Entities to expand their networks and capture untapped program value. By leveraging Highbridge, Sam’s Club will deliver standardized, scalable, and compliant 340B services across its pharmacy network: ensuring consistency, transparency, and growth potential for partners nationwide.

Expanding Access, Empowering Growth

Through this partnership, Sam’s Club and Pillr Health are delivering a scalable technology framework that streamlines 340B operations and strengthens collaboration across the program’s national network.

“This partnership represents a pivotal step forward for both organizations,” said Skip Devanny, CEO of Pillr Health. “By combining Sam’s Club’s national reach with Pillr’s advanced technology, we’re enabling a new era of collaboration and value creation across the 340B ecosystem.”

A Shared Commitment to the 340B Mission

At its core, this partnership is about more than technology. It is about advancing the mission of 340B by expanding access, improving affordability, and empowering providers to reinvest in patient care.

Through this collaboration, Sam’s Club and Pillr Health are building a strong foundation for sustained 340B growth, helping safety-net providers strengthen compliance, increase savings, and extend their impact in the communities that need it most.

Expert Tip: Maximize 340B Savings by Manually Pulling in Rejected and Qualified Claims

Manually pulling in rejected and qualified claims in the TPA database is a critical step in capturing eligible 340B savings that may have been missed due to unmatched prescription data. Claims can fail to match automatically to an EMR (Electronic Medical Record) or ERX (Electronic Prescription) record due to discrepancies in provider documentation, timing issues, or data entry errors. By reviewing and manually adjudicating these claims, covered entities (CEs) can identify encounters that still meet 340B eligibility requirements but were not captured through automated matching. This practice ensures the entity maximizes its 340B benefit while maintaining program compliance.

Furthermore, this manual reconciliation process supports stronger audit preparedness and data integrity. By documenting the rationale for qualifying claims and ensuring proper linkage to eligible encounters, CEs can provide a defensible audit trail. It also helps identify patterns in rejected claims that may point to workflow or system issues, allowing for targeted improvements. Ultimately, consistently reviewing and processing unmatched claims manually helps optimize program performance while upholding the accuracy and accountability essential in 340B operations.

Expert Tip: Maximize 340B Savings by Manually Pulling in Rejected and Qualified Claims

Manually pulling in rejected and qualified claims in the TPA database is a critical step in capturing eligible 340B savings that may have been missed due to unmatched prescription data. Claims can fail to match automatically to an EMR (Electronic Medical Record) or ERX (Electronic Prescription) record due to discrepancies in provider documentation, timing issues, or data entry errors. By reviewing and manually adjudicating these claims, covered entities (CEs) can identify encounters that still meet 340B eligibility requirements but were not captured through automated matching. This practice ensures the entity maximizes its 340B benefit while maintaining program compliance.

Furthermore, this manual reconciliation process supports stronger audit preparedness and data integrity. By documenting the rationale for qualifying claims and ensuring proper linkage to eligible encounters, CEs can provide a defensible audit trail. It also helps identify patterns in rejected claims that may point to workflow or system issues, allowing for targeted improvements. Ultimately, consistently reviewing and processing unmatched claims manually helps optimize program performance while upholding the accuracy and accountability essential in 340B operations.

Expert Tip: Maximize 340B Savings by Manually Pulling in Rejected and Qualified Claims

Manually pulling in rejected and qualified claims in the TPA database is a critical step in capturing eligible 340B savings that may have been missed due to unmatched prescription data. Claims can fail to match automatically to an EMR (Electronic Medical Record) or ERX (Electronic Prescription) record due to discrepancies in provider documentation, timing issues, or data entry errors. By reviewing and manually adjudicating these claims, covered entities (CEs) can identify encounters that still meet 340B eligibility requirements but were not captured through automated matching. This practice ensures the entity maximizes its 340B benefit while maintaining program compliance.

Furthermore, this manual reconciliation process supports stronger audit preparedness and data integrity. By documenting the rationale for qualifying claims and ensuring proper linkage to eligible encounters, CEs can provide a defensible audit trail. It also helps identify patterns in rejected claims that may point to workflow or system issues, allowing for targeted improvements. Ultimately, consistently reviewing and processing unmatched claims manually helps optimize program performance while upholding the accuracy and accountability essential in 340B operations.

Pillr Health Achieves Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) Registration as well as NCPDP Setup, Strengthening Support for Covered Entities

Pillr Health is proud to share that we are now officially registered as a Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) with the Centers for Medicare & Medicaid Services (CMS).

This milestone underscores Pillr Health’s role as a trusted partner in helping covered entities, pharmacies, and manufacturers navigate the evolving requirements of the Inflation Reduction Act (IRA) Maximum Fair Price (MFP) program.

Our technology and compliance platform is built to simplify complex processes—delivering seamless support across effectuation and reconciliation. In addition, Pillr Health has completed setup with the National Council for Prescription Drug Programs (NCPDP) as a Pharmacy Remit, Reconciliation, and Payment Vendor, further streamlining both operational and financial processes.

We remain committed to advancing solutions that empower healthcare organizations to thrive in today’s rapidly changing landscape.

Pillr Health Achieves Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) Registration as well as NCPDP Setup, Strengthening Support for Covered Entities

Pillr Health is proud to share that we are now officially registered as a Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) with the Centers for Medicare & Medicaid Services (CMS).

This milestone underscores Pillr Health’s role as a trusted partner in helping covered entities, pharmacies, and manufacturers navigate the evolving requirements of the Inflation Reduction Act (IRA) Maximum Fair Price (MFP) program.

Our technology and compliance platform is built to simplify complex processes—delivering seamless support across effectuation and reconciliation. In addition, Pillr Health has completed setup with the National Council for Prescription Drug Programs (NCPDP) as a Pharmacy Remit, Reconciliation, and Payment Vendor, further streamlining both operational and financial processes.

We remain committed to advancing solutions that empower healthcare organizations to thrive in today’s rapidly changing landscape.

Pillr Health Achieves Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) Registration as well as NCPDP Setup, Strengthening Support for Covered Entities

Pillr Health is proud to share that we are now officially registered as a Medicare Transaction Facilitator (MTF) Third-Party Support Entity (TPSE) with the Centers for Medicare & Medicaid Services (CMS).

This milestone underscores Pillr Health’s role as a trusted partner in helping covered entities, pharmacies, and manufacturers navigate the evolving requirements of the Inflation Reduction Act (IRA) Maximum Fair Price (MFP) program.

Our technology and compliance platform is built to simplify complex processes—delivering seamless support across effectuation and reconciliation. In addition, Pillr Health has completed setup with the National Council for Prescription Drug Programs (NCPDP) as a Pharmacy Remit, Reconciliation, and Payment Vendor, further streamlining both operational and financial processes.

We remain committed to advancing solutions that empower healthcare organizations to thrive in today’s rapidly changing landscape.

Ready to get started?

Ready to get started?

The Pillr Health team is here to empower your 340B program, and beyond. Reach out at the link below.

The Pillr Health team is here to empower your 340B program, and beyond. Reach out at the link below.

Ready to get started?

The Pillr Health team is here to empower your 340B program, and beyond. Reach out at the link below.